https://www.zonebourse.com/cours/action/BELITE-BIO-INC-136829476/actualite/Belite-Bio-Inc-annonce-la-soumission-a-la-PMDA-de-Tinlarebant-pour-un-essai-clinique-sur-la-malad-46264563/?utm_source=telegram&utm_medium=social&utm_campaign=share